{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:57:57Z","timestamp":1784516277112,"version":"3.55.0"},"reference-count":114,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Globally, cancer is considered as the major leading cause in decreasing the patient health care system of human beings. The growing threat from drug-resistant cancers makes heterocyclic moieties as an urgent need to develop more successful candidates for anti-cancer therapy. In view of outstanding pharmacological activities Quinolone and its derivatives have attracted more attention towards drug designing and biological evaluation in the search of new drug molecules. The inspired researchers attempted efforts in order to discover quinolone based analogs due to its wide range of biological activities. Due to immense pharmacological importance, distinct synthetic methods have been executed to attain new drug entities from quinolones and all the reported molecules have shown constructive anticancer activity. Some of the synthetic protocol like, one pot synthesis, post-Ugi-transformation, catalysed based synthesis, enzyme-based synthesis and nano-catalyst based synthetic procedures are also discussed as recent advancement in production of quinolone derivatives. In this review, recent synthetic approaches in the medicinal chemistry of quinolones and potent quinolone derivatives on the basis of structural activity relationship are outlined. Moreover, their major methods and modifications are discussed.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389557521666210112142136","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T10:31:39Z","timestamp":1610533899000},"page":"69-88","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Exploring Quinolone Scaffold: Unravelling the Chemistry of Anticancer Drug Design"],"prefix":"10.2174","volume":"22","author":[{"given":"Vishal","family":"Sharma","sequence":"first","affiliation":[{"name":"MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Hr 133207, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2535-2729","authenticated-orcid":true,"given":"Rina","family":"Das","sequence":"additional","affiliation":[{"name":"MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Hr 133207, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-7437","authenticated-orcid":true,"given":"Dinesh Kumar","family":"Mehta","sequence":"additional","affiliation":[{"name":"MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Hr 133207, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra-Hr"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Kumar","family":"Sahu","sequence":"additional","affiliation":[{"name":"Dept of Pharmaceutical Science, Assam University (A Central University), Silchar 788011, Assam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejmech.2018.10.037","volume":"161","author":"Rashid H.U.","year":"2019","unstructured":"Rashid H.U.; Xu Y.; Muhammad Y.; Wang L.; Jiang J.; Research advances on anticancer activities of matrine and its derivatives: An updated overview. Eur J Med Chem 2019,161,205-238","journal-title":"Eur J Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejps.2017.05.036","volume":"105","author":"Elghazawy N.H.","year":"2017","unstructured":"Elghazawy N.H.; Hefnawy A.; Sedky N.K.; El-Sherbiny I.M.; Arafa R.K.; Preparation and nanoformulation of new quinolone scaffold-based anticancer agents: Enhancing solubility for better cellular delivery. Eur J Pharm Sci 2017,105,203-211","journal-title":"Eur J Pharm Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.2174\/092986711797535326","volume":"18","author":"Sharma P.C.","year":"2011","unstructured":"Sharma P.C.; Kaur G.; Pahwa R.; Sharma A.; Rajak H.; Quinazolinone analogs as potential therapeutic agents. Curr Med Chem 2011,18(31),4786-4812","journal-title":"Curr Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1021\/acs.chemrev.7b00775","volume":"118","author":"Counihan J.L.","year":"2018","unstructured":"Counihan J.L.; Grossman E.A.; Nomura D.K.; Cancer metabolism: current understanding and therapies. Chem Rev 2018,118(14),6893-6923","journal-title":"Chem Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jcrpr.2017.07.001","volume":"4","author":"Hassanpour S.H.","year":"2017","unstructured":"Hassanpour S.H.; Dehghani M.; Review of cancer from perspective of molecular. J Cancer Res Pract 2017,4(4),127-129","journal-title":"J Cancer Res Pract"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"Jemal A.","year":"2011","unstructured":"Jemal A.; Bray F.; Center M.M.; Ferlay J.; Ward E.; Forman D.; Global cancer statistics. CA cancer J Clin 2011,61(2),69-90","journal-title":"CA cancer J Clin"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijhydene.2020.06.122","author":"Heidari-Asil S.A.","year":"2020","unstructured":"Heidari-Asil S.A.; Zinatloo-Ajabshir S.; Amiri O.; Salavati-Niasari M.; Amino acid assisted-synthesis and characterization of magnetically retrievable ZnCo2O4\u2013Co3O4 nanostructures as high activity visible-light-driven photocatalyst. Int J Hydrogen Energy 2020","journal-title":"Int J Hydrogen Energy"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijhydene.2019.05.137","author":"Zinatloo-Ajabshir S.","year":"2019","unstructured":"Zinatloo-Ajabshir S.; Salehi Z.; Amiri O.; Salavati-Niasari M.; Green synthesis, characterization and investigation of the electrochemical hydrogen storage properties of Dy2Ce2O7 nanostructures with fig extract. Int J Hydrogen Energy 2019","journal-title":"Int J Hydrogen Energy"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1016\/j.tetlet.2014.07.123","volume":"55","author":"Banerjee S.","year":"2014","unstructured":"Banerjee S.; Payra S.; Saha A.; Sereda G.; ZnO nanoparticles: a green efficient catalyst for the room temperature synthesis of biologically active 2-aryl-1,3-benzothiazole and 1,3-benzoxazole derivatives. Tetrahedron Lett 2014,55(40),5515-5520","journal-title":"Tetrahedron Lett"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jallcom.2019.04.005","volume":"791","author":"Zinatloo-Ajabshir S.","year":"2019","unstructured":"Zinatloo-Ajabshir S.; Salehi Z.; Amiri O.; Salavati-Niasari M.; Simple fabrication of Pr2Ce2O7 nanostructures via a new and eco-friendly route; A potential electrochemical hydrogen storage material. J Alloys Compd 2019,791,792-799","journal-title":"J Alloys Compd"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.18596\/jotcsa.55734","volume":"3","author":"Ozdemir S.B.","year":"2016","unstructured":"Ozdemir S.B.; Synthesis of novel fluoroquinolone-triazole hybrid compounds as antimicrobial agents. J Turkish Chem Soc Sect A: Chem 2016,3(3),515-534","journal-title":"J Turkish Chem Soc Sect A: Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1021\/jm501881c","volume":"58","author":"Bisacchi G.S.","year":"2015","unstructured":"Bisacchi G.S.; Origins of the quinolone class of antibacterials: an expanded &#x201C;discoverystory&#x201D;. J Med Chem 2015,58(12),4874-4882","journal-title":"J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1574-6976.2010.00247.x","volume":"35","author":"Heeb S.","year":"2011","unstructured":"Heeb S.; Fletcher M.P.; Chhabra S.R.; Diggle S.P.; Williams P.; C&#xE1;mara M.; Quinolones: from antibiotics to autoinducers. FEMS Microbiol Rev 2011,35(2),247-274","journal-title":"FEMS Microbiol Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","volume":"141","author":"Hu Y.Q.","year":"2017","unstructured":"Hu Y.Q.; Zhang S.; Xu Z.; Lv Z.S.; Liu M.L.; Feng L.S.; 4-Quinolone hybrids and their antibacterial activities. Eur J Med Chem 2017,141,335-345","journal-title":"Eur J Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","volume":"146","author":"Zhang G.F.","year":"2018","unstructured":"Zhang G.F.; Liu X.; Zhang S.; Pan B.; Liu M.L.; Ciprofloxacin derivatives and their antibacterial activities. Eur J Med Chem 2018,146,599-612","journal-title":"Eur J Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ejmech.2018.01.080","volume":"146","author":"Fan Y.L.","year":"2018","unstructured":"Fan Y.L.; Wu J.B.; Cheng X.W.; Zhang F.Z.; Feng L.S.; Fluoroquinolone derivatives and their anti-tubercular activities. Eur J Med Chem 2018,146,554-563","journal-title":"Eur J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejmech.2017.05.057","volume":"138","author":"Xu Z.","year":"2017","unstructured":"Xu Z.; Song X.F.; Hu Y.Q.; Qiang M.; Lv Z.S.; Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation. Eur J Med Chem 2017,138,66-71","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","volume":"146","author":"Fan Y.L.","year":"2018","unstructured":"Fan Y.L.; Cheng X.W.; Wu J.B.; Liu M.; Zhang F.Z.; Xu Z.; Feng L.S.; Antiplasmodial and antimalarial activities of quinolone derivatives: An overview. Eur J Med Chem 2018,146,1-14","journal-title":"Eur J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.exppara.2010.10.016","volume":"127","author":"Winter R.","year":"2011","unstructured":"Winter R.; Kelly J.X.; Smilkstein M.J.; Hinrichs D.; Koop D.R.; Riscoe M.K.; Optimization of endochin-like quinolones for antimalarial activity. Exp Parasitol 2011,127(2),545-551","journal-title":"Exp Parasitol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bioorg.2017.09.015","volume":"75","author":"Sekgota K.C.","year":"2017","unstructured":"Sekgota K.C.; Majumder S.; Isaacs M.; Mnkandhla D.; Hoppe H.C.; Khanye S.D.; Kriel F.H.; Coates J.; Kaye P.T.; Application of the Morita-Baylis-Hillman reaction in the synthesis of 3-[(N-cycloalkylbenzamido)methyl]-2-quinolones as potential HIV-1 integrase inhibitors. Bioorg Chem 2017,75,310-316","journal-title":"Bioorg Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1021\/jm701585h","volume":"51","author":"Tabarrini O.","year":"2008","unstructured":"Tabarrini O.; Massari S.; Daelemans D.; Stevens M.; Manfroni G.; Sabatini S.; Balzarini J.; Cecchetti V.; Pannecouque C.; Fravolini A.; Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. J Med Chem 2008,51(17),5454-5458","journal-title":"J Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","volume":"165","author":"Gao F.","year":"2019","unstructured":"Gao F.; Zhang X.; Wang T.; Xiao J.; Quinolone hybrids and their anti-cancer activities: An overview. Eur J Med Chem 2019,165,59-79","journal-title":"Eur J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/1475-2875-13-339","volume":"13","author":"Beteck R.M.","year":"2014","unstructured":"Beteck R.M.; Smit F.J.; Haynes R.K.; N\u2019Da D.D.; Recent progress in the development of anti-malarial quinolones. Malar J 2014,13,339","journal-title":"Malar J"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejmech.2018.02.083","volume":"150","author":"Hepnarova V.","year":"2018","unstructured":"Hepnarova V.; Korabecny J.; Matouskova L.; Jost P.; Muckova L.; Hrabinova M.; Vykoukalova N.; Kerhartova M.; Kucera T.; Dolezal R.; Nepovimova E.; Spilovska K.; Mezeiova E.; Pham N.L.; Jun D.; Staud F.; Kaping D.; Kuca K.; Soukup O.; The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer\u2019s disease. Eur J Med Chem 2018,150,292-306","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bioorg.2018.03.017","volume":"78","author":"Mermer A.","year":"2018","unstructured":"Mermer A.; Demirba&#x15F; N.; &#x15E;irin Y.; Uslu H.; &#xD6;zdemir Z.; Demirba&#x15F; A.; Conventional and microwave prompted synthesis, antioxidant, anticholinesterase activity screening and molecular docking studies of new quinolone-triazole hybrids. Bioorg Chem 2018,78,236-248","journal-title":"Bioorg Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"18636","DOI":"10.1074\/jbc.M112.345678","volume":"287","author":"Tretter E.M.","year":"2012","unstructured":"Tretter E.M.; Berger J.M.; Mechanisms for defining supercoiling set point of DNA gyrase orthologs: I. A nonconserved acidic C-terminal tail modulates escherichia coli gyrase activity. J Biol Chem 2012,287(22),18636-18644","journal-title":"J Biol Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"Aldred K.J.","year":"2014","unstructured":"Aldred K.J.; Kerns R.J.; Osheroff N.; Mechanism of quinolone action and resistance. Biochemistry 2014,53(10),1565-1574","journal-title":"Biochemistry"},{"key":"ref=28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000154","volume":"4","author":"Sidhu G.S.","year":"2017","unstructured":"Sidhu G.S.; Go A.; Attar B.M.; Mutneja H.R.; Arora S.; Patel S.A.; Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: A systematic review. BMJ Open Gastro 2017,4(1)","journal-title":"BMJ Open Gastro"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/jhet.3153","volume":"55","author":"Makhanya T.R.","year":"2018","unstructured":"Makhanya T.R.; Gengan R.M.; Pandian P.; Chuturgoon A.A.; Tiloke C.; Atar A.; Phosphotungstic acid catalyzed one pot synthesis of 4,8,8-trimethyl-5- phenyl-5,5a,8,9-tetrahydrobenzo[b][1,8]naphthyridin-6(7H)-one derivatives and their biological evaluation against A549 lung cancer cells. J Heterocycl Chem 2018,55(5),1193-1204","journal-title":"J Heterocycl Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/17460441.2017.1319357","volume":"12","author":"Musiol R.","year":"2017","unstructured":"Musiol R.; An overview of quinoline as a privileged scaffold in cancer drug discovery. Expert Opin Drug Discov 2017,12(6),583-597","journal-title":"Expert Opin Drug Discov"},{"key":"ref=31","first-page":"1","volume":"351","author":"Ezerlarab H.A.A.","year":"2018","unstructured":"Ezerlarab H.A.A.; Abbas S.H.; Hassan H.A.; Abuo-Rahma G.E.A.; Recent updates of fluoroquinolones as antibacterial agents. Arch Pharm 2018,351(9),1-13","journal-title":"Arch Pharm"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejmech.2018.10.035","volume":"161","author":"Chu X.M.","year":"2019","unstructured":"Chu X.M.; Wang C.; Liu W.; Liang L-L.; Gong K-K.; Zhao C-Y.; Sun K.L.; Quinoline and quinolone dimers and their biological activities: An overview. Eur J Med Chem 2019,161,101-117","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1016\/j.bmcl.2015.06.068","volume":"25","author":"Raghavan S.","year":"2015","unstructured":"Raghavan S.; Manogaran P.; Gadepalli Narasimha K.K.; Kalpattu Kuppusami B.; Mariyappan P.; Gopalakrishnan A.; Venkatraman G.; Synthesis and anticancer activity of novel curcumin-quinolone hybrids. Bioorg Med Chem Lett 2015,25(17),3601-3605","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4161\/cbt.7.1.5136","volume":"7","author":"Smart D.J.","year":"2008","unstructured":"Smart D.J.; Halicka H.D.; Traganos F.; Darzynkiewicz Z.; Williams G.M.; Ciprofloxacin-induced G2 arrest and apoptosis in TK6 lymphoblastoid cells is not dependent on DNA double-strand break formation. Cancer Biol Ther 2008,7(1),113-119","journal-title":"Cancer Biol Ther"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biopha.2018.12.119","volume":"111","author":"Yadav V.","year":"2019","unstructured":"Yadav V.; Talwar P.; Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth. Biomed Pharmacother 2019,111,934-946","journal-title":"Biomed Pharmacother"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejphar.2018.08.002","volume":"835","author":"Beberok A.","year":"2018","unstructured":"Beberok A.; Rzepka Z.; Respondek M.; Rok J.; Sierotowicz D.; Wrze&#x15B;niok D.; GSH depletion, mitochondrial membrane breakdown, caspase-3\/7 activation and DNA fragmentation in U87MG glioblastoma cells: New insight into the mechanism of cytotoxicity induced by fluoroquinolones. Eur J Pharmacol 2018,835,94-107","journal-title":"Eur J Pharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/153765291009877","volume":"15","author":"G&#xFC;rbay A.","year":"2005","unstructured":"G&#xFC;rbay A.; Osman M.; Favier A.; Hincal F.; Ciprofloxacin-induced cytotoxicity and apoptosis in HeLa cells. Toxicol Mech Methods 2005,15(5),339-342","journal-title":"Toxicol Mech Methods"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/aps.2011.158","volume":"33","author":"Shi Z.Y.","year":"2012","unstructured":"Shi Z.Y.; Li Y.Q.; Kang Y.H.; Hu G.Q.; Huang-fu C.S.; Deng J.B.; Liu B.; Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells. Acta Pharmacol Sin 2012,33(2),271-278","journal-title":"Acta Pharmacol Sin"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2008-2231-20-16","volume":"20","author":"Mohammadhosseini N.","year":"2012","unstructured":"Mohammadhosseini N.; Alipanahi Z.; Alipour E.; Emami S.; Faramarzi M.A.; Samadi N.; Khoshnevis N.; Shafiee A.; Foroumadi A.; Synthesis and antibacterial activity of novel levofloxacin derivatives containing a substituted thienylethyl moiety. Daru 2012,20(1),16","journal-title":"Daru"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1248\/cpb.c13-00797","volume":"62","author":"Rajulu G.G.","year":"2014","unstructured":"Rajulu G.G.; Bhojya Naik H.S.; Viswanadhan A.; Thiruvengadam J.; Rajesh K.; Ganesh S.; Jagadheshan H.; Kesavan P.K.; New hydroxamic acid derivatives of fluoroquinolones: Synthesis and evaluation of antibacterial and anticancer properties. Chem Pharm Bull (Tokyo) 2014,62(2),168-175","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201800376","volume":"352","author":"Abdel-Aal M.A.A.","year":"2019","unstructured":"Abdel-Aal M.A.A.; Abdel-Aziz S.A.; Shaykoon M.S.A.; Abuo-Rahma G.E.A.; Towards anticancer fluoroquinolones: A review article. Arch Pharm (Weinheim) 2019,352(7)","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/5584_2019_428","volume":"Vol. 1282","author":"Senerovic L.","year":"2019","unstructured":"Senerovic L.; Opsenica D.; Moric I.; Aleksic I.; Spasic M.; Vasiljevic B.; Quinolines and quinolones as antibacterial, antifungal, anti-virulence, antiviral and anti-parasitic agentsadvances in microbiology, infectious Diseases and Public Health advances in experimental medicine and biology 2019,Vol. 1282,37-69","journal-title":"Quinolines and quinolones as antibacterial, antifungal, anti-virulence, antiviral and anti-parasitic agentsadvances in microbiology, infectious Diseases and Public Health advances in experimental medicine and biology"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.4028\/www.scientific.net\/AMR.634-638.1116","volume":"634-638","author":"Xu X.M.","year":"2013","unstructured":"Xu X.M.; Luo Z.G.; He K.; Zhang M.Y.; Synthesis and Biological Evaluation of Quinolone Acid Derivatives Having Polyhydroxylated Aromatics as HIV-1 Integrase Inhibitions. Adv Mat Res 2013,634-638,1116-1119","journal-title":"Adv Mat Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"10652","DOI":"10.3390\/molecules170910652","volume":"17","author":"Hu L.","year":"2012","unstructured":"Hu L.; Yan S.; Luo Z.; Han X.; Wang Y.; Wang Z.; Zeng C.; Design, practical synthesis, and biological evaluation of novel 6-(pyrazolylmethyl)-4-quinoline-3-carboxylic acid derivatives as HIV-1 integrase inhibitors. Molecules 2012,17(9),10652-10666","journal-title":"Molecules"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.biopha.2008.01.016","volume":"63","author":"Foroumadi A.","year":"2009","unstructured":"Foroumadi A.; Emami S.; Rajabalian S.; Badinloo M.; Mohammadhosseini N.; Shafiee A.; N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study. Biomed Pharmacother 2009,63(3),216-220","journal-title":"Biomed Pharmacother"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejmech.2012.07.010","volume":"55","author":"Feng L.","year":"2012","unstructured":"Feng L.; Lv K.; Liu M.; Wang S.; Zhao J.; You X.; Li S.; Cao J.; Guo H.; Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety. Eur J Med Chem 2012,55,125-136","journal-title":"Eur J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ardp.200900191","volume":"343","author":"Zhang Y.B.","year":"2010","unstructured":"Zhang Y.B.; Feng L.S.; You X.F.; Guo Q.; Guo H.Y.; Liu M.L.; Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives. Arch Pharm (Weinheim) 2010,343(3),143-151","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ancr.2014.06.001","volume":"1","author":"Asif M.","year":"2014","unstructured":"Asif M.; A review on anticancer and antimicrobial activity of tetrafluoroquinolone compounds. Annals Med Chem Res 2014,1(1),1-10","journal-title":"Annals Med Chem Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/jhet.3244","volume":"55","author":"Jiang D.","year":"2018","unstructured":"Jiang D.; 4-Quinolone derivatives and their activities against gram-negative pathogens. J Heterocycl Chem 2018,55,2003","journal-title":"J Heterocycl Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1007\/s00044-013-0897-5","volume":"23","author":"Adhikari N.","year":"2014","unstructured":"Adhikari N.; Halder A.K.; Mondal C.; Jha T.; Structural findings of quinolone carboxylic acids in cytotoxic, antiviral, and anti-HIV-1 integrase activity through validated comparative molecular modeling studies. Med Chem Res 2014,23,3096-3127","journal-title":"Med Chem Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ardp.201100316","volume":"345","author":"Gupta M.","year":"2012","unstructured":"Gupta M.; Madan A.K.; Diverse models for the prediction of HIV integrase inhibitory activity of substituted quinolone carboxylic acids. Arch Pharm (Weinheim) 2012,345(12),989-1000","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ardp.201900045","author":"Wang R.","year":"2019","unstructured":"Wang R.; Xu K.; Shi W.; Quinolone derivatives: Potential anti\u2010HIV agent\u2014development and application. Archiv. Der. Pharmazie 2019,1-17","journal-title":"Pharmazie"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ejmech.2018.12.001","volume":"163","author":"Gao C.","year":"2019","unstructured":"Gao C.; Chang L.; Xu Z.; Yan X-F.; Ding C.; Zhao F.; Wu X.; Feng L.S.; Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents. Eur J Med Chem 2019,163,404-412","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/aid.2013.0154","volume":"30","author":"Royle C.M.","year":"2014","unstructured":"Royle C.M.; Tsai M-H.; Tabarrini O.; Massari S.; Graham D.R.; Aquino V.N.; Boasso A.; Modulation of HIV-1-induced activation of plasmacytoid dendritic cells by 6-desfluoroquinolones. AIDS Res Hum Retroviruses 2014,30(4),345-354","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201800141","author":"Ezelarab H.A.A.","year":"2018","unstructured":"Ezelarab H.A.A.; Abbas S.H.; Hassan H.A.; Abuo-Rahma G.E-D.A.; Recent updates of fluoroquinolones as antibacterial agents. Archiv Der Pharmazie 2018","journal-title":"Archiv Der Pharmazie"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/10426507.2017.1394302","volume":"193","author":"Parizadeh N.","year":"2017","unstructured":"Parizadeh N.; Alipour E.; Soleymani S.; Zabihollahi R.; Aghasadeghi M.R.; Hajimahdi Z.; Zarghi A.; Synthesis of novel 3-(5-(Alkyl\/arylthio)-1,3,4-Oxadiazol-2-yl)-8-Phenylquinolin-4(1H)-one derivatives as anti-HIV agents. Phosphorus Sulfur Silicon Relat Elem 2017,193(4),225-231","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.ejmech.2018.08.095","volume":"157","author":"Gao F.","year":"2018","unstructured":"Gao F.; Wang P.; Yang H.; Miao Q.; Ma L.; Lu G.; Recent developments of quinolone-based derivatives and their activities against Escherichia coli. Eur J Med Chem 2018,157,1223-1248","journal-title":"Eur J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ardp.200700090","volume":"341","author":"Emami S.","year":"2008","unstructured":"Emami S.; Foroumadi A.; Faramarzi M.A.; Samadi N.; Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety. Arch Pharm (Weinheim) 2008,341(1),42-48","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"10989","DOI":"10.1021\/acs.joc.7b01932","volume":"82","author":"Biswas A.","year":"2017","unstructured":"Biswas A.; Giri D.; Das D.; De A.; Patra S.K.; Samanta R.; A mild rhodium catalyzed direct synthesis of quinolones from pyridones: application in the detection of nitroaromatics. J Org Chem 2017,82(20),10989-10996","journal-title":"J Org Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"8321","DOI":"10.1021\/jm200718m","volume":"54","author":"Cross R.M.","year":"2011","unstructured":"Cross R.M.; Namelikonda N.K.; Mutka T.S.; Luong L.; Kyle D.E.; Manetsch R.; Synthesis, antimalarial activity, and structure-activity relationship of 7-(2-phenoxyethoxy)-4(1H)-quinolones. J Med Chem 2011,54(24),8321-8327","journal-title":"J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ejmech.2013.03.011","volume":"63","author":"Suthar S.K.","year":"2013","unstructured":"Suthar S.K.; Jaiswal V.; Lohan S.; Bansal S.; Chaudhary A.; Tiwari A.; Alex A.T.; Joesph A.; Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: design, synthesis and biological screening. Eur J Med Chem 2013,63,589-602","journal-title":"Eur J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1248\/cpb.c13-00040","volume":"61","author":"Shou K.J.","year":"2013","unstructured":"Shou K.J.; Li J.; Jin Y.; Lv Y.W.; Design, synthesis, biological evaluation, and molecular docking studies of quinolone derivatives as potential antitumor topoisomerase I inhibitors. Chem Pharm Bull (Tokyo) 2013,61(6),631-636","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1515\/gps-2012-0083","volume":"2","author":"Duarte P.D.","year":"2013","unstructured":"Duarte P.D.; Paixao M.W.; Correa A.G.; Microwave assisted synthesis of 4-quinolones and N, N\u2032-diarylureas. Green Process Synth 2013,2(1),19-24","journal-title":"Green Process Synth"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4172\/1989-8436.100061","volume":"7","author":"Voigt B.","year":"2016","unstructured":"Voigt B.; Albrecht D.; Dalhoff A.; Mode of action of mcb3681 in staphylococcus aureus\u2013 a proteomic study. Arch Clin Microbiol 2016,7,6","journal-title":"Arch Clin Microbiol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"02077","DOI":"10.1128\/AAC.02077-16","volume":"61","author":"Freeman J.","year":"2017","unstructured":"Freeman J.; Pilling S.; Vernon J.; Wilcox M.H.; In vitro activities of mcb3681 and eight comparators against clostridium difficile isolates with known ribotypes and diverse geographical spread. Antimicrob Agents Chemother 2017,61(3),02077-16","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1021\/ol303546p","volume":"15","author":"Nakai K.","year":"2013","unstructured":"Nakai K.; Kurahashi T.; Matsubara S.; Synthesis of quinolones by nickel-catalyzed cycloaddition via elimination of nitrile. Org Lett 2013,15(4),856-859","journal-title":"Org Lett"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.3762\/bjoc.14.234","volume":"14","author":"Du X.","year":"2018","unstructured":"Du X.; Huang J.; Nechaev A.A.; Yao R.; Gong J.; Van der Eycken E.V.; Pereshivko O.P.; Peshkov V.A.; Gold-catalyzed post-Ugi alkyne hydroarylation for the synthesis of 2-quinolones. Beilstein J Org Chem 2018,14,2572-2579","journal-title":"Beilstein J Org Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.tet.2019.03.026","volume":"75","author":"Singh K.","year":"2019","unstructured":"Singh K.; Malviya B.K.; Verma V.P.; Badsara S.S.; Bhardwaj V.K.; Sharma S.; Cationic Pd(II) catalyzed regioselective intramolecular hydroarylation for the efficient synthesis of 4-aryl-2-quinolones. Tetrahedron 2019,75(17),2506-2520","journal-title":"Tetrahedron"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1074\/jbc.M112.429886","volume":"288","author":"Resmi M.S.","year":"2013","unstructured":"Resmi M.S.; Verma P.; Gokhale R.S.; Soniya E.V.; Identification and characterization of a type III polyketide synthase involved in quinolone alkaloid biosynthesis from Aegle marmelos Correa. J Biol Chem 2013,288(10),7271-7281","journal-title":"J Biol Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"13459","DOI":"10.1021\/acs.joc.7b02498","volume":"82","author":"Gao W.C.","year":"2017","unstructured":"Gao W.C.; Liu T.; Cheng Y-F.; Chang H-H.; Li X.; Zhou R.; Wei W.L.; Qiao Y.; AlCl3-catalyzed intramolecular cyclization of n-arylpropynamides with n-sulfanylsuccinimides: divergent synthesis of 3-sulfenyl quinolin-2-ones and azaspiro [4, 5] trienones. J Org Chem 2017,82(24),13459-13467","journal-title":"J Org Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1055\/s-0036-1588470","volume":"28","author":"Jarriage L.","year":"2017","unstructured":"Jarriage L.; Zaied S.; Merad J.; Blanchard F.; Masson G.; Easy access to quinolin- 2(1H)-ones via a one pot tandem Oxa-Michael-Aldol sequence. Synlett 2017,28(14),1724-1728","journal-title":"Synlett"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fpls.2012.00057","volume":"3","author":"Shimokawa Y.","year":"2012","unstructured":"Shimokawa Y.; Morita H.; Abe I.; Benzalacetone synthase. Front Plant Sci 2012,3,57-62","journal-title":"Front Plant Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1021\/acs.orglett.6b01501","volume":"18","author":"Wang J.","year":"2016","unstructured":"Wang J.; Wang X-H.; Liu X.; Li J.; Shi X-P.; Song Y-L.; Zeng K-W.; Zhang L.; Tu P-F.; Shi S-P.; Synthesis of unnatural 2- substituted quinolones and 1,3-diketones by a member of type III polyketide synthases from huperzia serrata. Org Lett 2016,18(15),3550-3553","journal-title":"Org Lett"},{"key":"ref=74","author":"Zhang P.","year":"2014","unstructured":"Zhang P.; Zheng H.; Gu H.; Zhang W.; Wang N.; 2014"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1039\/C4GC01606H","volume":"17","author":"Shen C.","year":"2015","unstructured":"Shen C.; Shen H.Y.; Yang M.; Xia C.C.; Zhang P.F.; A novel D-glucosaminederived pyridyl-triazole@ palladium catalyst for solvent-free Mizoroki\u2013Heck reactions and its application in the synthesis of axitinib. Green Chem 2015,17,225-230","journal-title":"Green Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1039\/C5CY00013K","volume":"5","author":"Shen H.","year":"2015","unstructured":"Shen H.; Shen C.; Chen C.; Wang A.; Zhang P.; Novel glycosyl pyridyltriazole@ palladium nanoparticles: efficient and recoverable catalysts for C-C cross couplings. Catal Sci Technol 2015,5,2065-2071","journal-title":"Catal Sci Technol"},{"key":"ref=77","first-page":"1021","author":"Rueping M.","year":"2015","unstructured":"Rueping M.; Moreth S.A.; Bolte M.Z.; Asymmetric br&#xF8;nsted acid-catalyzed intramolecular aza-Michael reaction enantioselective synthesis of dihydroquinolinones 2015,1021-1029","journal-title":"Asymmetric br&#xF8;nsted acid-catalyzed intramolecular aza-Michael reaction enantioselective synthesis of dihydroquinolinones"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"16494","DOI":"10.1039\/C8RA02578A","volume":"8","author":"Wang X.","year":"2018","unstructured":"Wang X.; Jiang X.; Sun S.; Liu Y.; Synthesis and biological evaluation of novel quinolone derivatives dual targeting histone deacetylase and tubulin polymerization as antiproliferative agents. RSC Advances 2018,8(30),16494-16502","journal-title":"RSC Advances"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bioorg.2018.10.058","volume":"83","author":"Khalil O.M.","year":"2019","unstructured":"Khalil O.M.; Gedawy E.M.; El-Malah A.A.; Adly M.E.; Novel nalidixic acid derivatives targeting topoisomerase II enzyme; Design, synthesis, anticancer activity and effect on cell cycle profile. Bioorg Chem 2019,83,262-276","journal-title":"Bioorg Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.bmcl.2018.03.085","volume":"28","author":"Towle T.R.","year":"2018","unstructured":"Towle T.R.; Kulkarni C.A.; Oppegard L.M.; Williams B.P.; Picha T.A.; Hiasa H.; Kerns R.J.; Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyrase. Bioorg Med Chem Lett 2018,28(10),1903-1910","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=81","first-page":"1","volume":"2","author":"Das R.","year":"2017","unstructured":"Das R.; Mehta D.K.; Sharma V.; Quinolones: Understanding the drug designing to combat drug resistance. Anal in Pharmacology and Pharmaceutics 2017,2(17),1-3","journal-title":"Anal in Pharmacology and Pharmaceutics"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejmech.2014.08.063","volume":"86","author":"Cui S.F.","year":"2014","unstructured":"Cui S.F.; Peng L.P.; Zhang H.Z.; Rasheed S.; Vijaya Kumar K.; Zhou C.H.; Novel hybrids of metronidazole and quinolones: Synthesis, bioactive evaluation, cytotoxicity, preliminary antimicrobial mechanism and effect of metal ions on their transportation by human serum albumin. Eur J Med Chem 2014,86,318-334","journal-title":"Eur J Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1248\/cpb.c17-00035","volume":"66","author":"Li J.","year":"2018","unstructured":"Li J.; Zheng T.C.; Jin Y.; Xu J.G.; Yu J.G.; Lv Y.W.; Synthesis, molecular docking and biological evaluation of quinolone derivatives as novel anticancer agents. Chem Pharm Bull (Tokyo) 2018,66(1),55-60","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1016\/j.bmcl.2013.06.083","volume":"23","author":"Cheng Y.Y.","year":"2013","unstructured":"Cheng Y.Y.; Liu C.Y.; Tsai M.T.; Lin H.Y.; Yang J.S.; Wu T.S.; Kuo S.C.; Huang L.J.; Lee K.H.; Design, synthesis, and mechanism of action of 2-(3-hydroxy-5-methoxyphenyl)-6-pyrrolidinylquinolin-4-one as a potent anticancer lead. Bioorg Med Chem Lett 2013,23(18),5223-5227","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.2174\/1871520619666190319142934","volume":"19","author":"Mohamed H.A.E.","year":"2019","unstructured":"Mohamed H.A.E.; Al-Shareef H.F.; Design, synthesis, anti-proliferative evaluation and cell cycle analysis of hybrid 2-quinolones. anticancer. Agents Med Chem 2019,19(9),1132-1140","journal-title":"Agents Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bmc.2013.11.047","volume":"22","author":"Rajput S.","year":"2014","unstructured":"Rajput S.; Gardner C.R.; Failes T.W.; Arndt G.M.; Black D.S.; Kumar N.; Synthesis and anticancer evaluation of 3-substituted quinolin-4-ones and 2,3-dihydroquinolin-4-ones. Bioorg Med Chem 2014,22(1),105-115","journal-title":"Bioorg Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00767","volume":"4","author":"Jean J.","year":"2018","unstructured":"Jean J.; Farrell D.S.; Farrelly A.M.; Toomey S.; Barlow J.W.; Design, synthesis and evaluation of novel 2,2-dimethyl-2,3-dihydroquinolin-4(1H)-one based chalcones as cytotoxic agents. Heliyon 2018,4(9)","journal-title":"Heliyon"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1039\/C8OB90031K","volume":"16","author":"Kumari P.","year":"2018","unstructured":"Kumari P.; Narayana C.; Dubey S.; Gupta A.; Sagar R.; Correction: Stereoselective synthesis of natural product inspired carbohydrate fused pyrano[3,2-c]quinolones as antiproliferative agents. Org Biomol Chem 2018,16(12),2185","journal-title":"Org Biomol Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1007\/s00044-017-1839-4","volume":"26","author":"Lamie P.F.","year":"2017","unstructured":"Lamie P.F.; Philoppes J.N.; Design and synthesis of three series of novel antitumor\u2013azo derivatives. Med Chem Res 2017,26,1228-1240","journal-title":"Med Chem Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00044-018-2259-9","volume":"28","author":"Hassanin H.M.","year":"2018","unstructured":"Hassanin H.M.; Elmoneam W.R.A.; Mostafa M.A.; Synthesis and antitumor activity evaluation of different 2,5-dialkyloxazolopyrano[3,2-c] quinolinone derivatives. Med Chem Res 2018,28,28-38","journal-title":"Med Chem Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1016\/j.bmc.2016.07.070","volume":"24","author":"Mohammed H.H.H.","year":"2016","unstructured":"Mohammed H.H.H.; Abd El-Hafeez A.A.; Abbas S.H.; Abdelhafez E.M.N.; Abuo-Rahma G.E.A.; New antiproliferative 7-(4-(N-substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2\/M phase. Bioorg Med Chem 2016,24(19),4636-4646","journal-title":"Bioorg Med Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ejmech.2017.09.017","volume":"140","author":"Zhang Z.","year":"2017","unstructured":"Zhang Z.; Xiao X.; Su T.; Wu J.; Ren J.; Zhu J.; Zhang X.; Cao R.; Du R.; Synthesis, structure-activity relationships and preliminary mechanism of action of novel water-soluble 4-quinolone-3-carboxamides as antiproliferative agents. Eur J Med Chem 2017,140,239-251","journal-title":"Eur J Med Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ejmech.2018.03.026","volume":"150","author":"Kassab A.E.","year":"2018","unstructured":"Kassab A.E.; Gedawy E.M.; Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity. Eur J Med Chem 2018,150,403-418","journal-title":"Eur J Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00706-018-2215-x","volume":"149","author":"Fedorowicz J.","year":"2018","unstructured":"Fedorowicz J.; S\u0105czewski J.; Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules. MonatshefteF&#xFC;rChemie - Chemical Monthly 2018,149(7),1199-1245","journal-title":"MonatshefteF&#xFC;rChemie - Chemical Monthly"},{"key":"ref=95","author":"Wang J.","year":"2019","unstructured":"Wang J.; Tsao A.; Liu X.; Class of quinolone heterocyclic aromatic molecules for cancer treatment 2019","journal-title":"Class of quinolone heterocyclic aromatic molecules for cancer treatment"},{"key":"ref=96","author":"Soong J.","year":"2017","unstructured":"Soong J.; Combination therapy of tetracyclic quinolone analogs for treating cancer 2017","journal-title":"Combination therapy of tetracyclic quinolone analogs for treating cancer"},{"key":"ref=97","author":"Kuo S.C.","year":"2015","unstructured":"Kuo S.C.; Teng C.M.; Lee K.H.; Huang L.J.; Chou L.C.; Chang C.S.; Sun C.M.; Wu T.S.; Pan S.L.; Way T.D.; Lee J.C.; Chung J.G.; Yang J.S.; Chen C.T.; Huang C.C.; Huang S.M.; Phenyl-4-quinolones as anticancer agents 2015","journal-title":"Phenyl-4-quinolones as anticancer agents"},{"key":"ref=98","author":"Wu T.S.","year":"2014","unstructured":"Wu T.S.; Pan S.L.; Way T.D.; Lee J.C.; Chung J.G.; Yang J.S.; Chen C.T.; Huang C.C.; Chou L.C.; Kuo S.C.; Teng C.M.; Lee K.H.; Huang L.J.; Huang S.M.; Chang C.S.; Sun C.M.; Selenophene-4-quinolones as anticancer agents 2014","journal-title":"Selenophene-4-quinolones as anticancer agents"},{"key":"ref=99","author":"Kuo S.C.","year":"2013","unstructured":"Kuo S.C.; Lee K.H.; Huang L.J.; Chou L.C.; Wu T.S.; Way T.D.; Chung J.G.; Yang J.S.; Huang C.H.; Tsai M.T.; Synthesis and anticancer activity of aryl and heteroaryl-quinoline derivatives 2013","journal-title":"Synthesis and anticancer activity of aryl and heteroaryl-quinoline derivatives"},{"key":"ref=100","author":"Kuo S.C.","year":"2013","unstructured":"Kuo S.C.; Teng C.M.; Lee K.H.; Huang L. J.; Chou L.C.; Chang C.S.; Sun C.M.; Wu T.S.; Pan S.L.; Way T.D.; Lee J. C.; Chung J.G.; Yang J.S.; Chen C.T.; Huang C.C.; Huang S.M.; Hydrophilic derivatives of 2-Aryl-4-quinolones as anticancer agents 2013","journal-title":"Hydrophilic derivatives of 2-Aryl-4-quinolones as anticancer agents"},{"key":"ref=101","author":"Tang J.C.O.","year":"2012","unstructured":"Tang J.C.O.; Chan A.S.C.; Lam K. H.; Chan S. H.; Quinoline derivatives as anticancer agents 2012","journal-title":"Quinoline derivatives as anticancer agents"},{"key":"ref=102","author":"Chang C.S.","year":"2009","unstructured":"Chang C.S.; Chen C. T.; Chou L.C.; Chung J.G.; Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents 2009","journal-title":"Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents"},{"key":"ref=103","author":"Khire U.","year":"2007","unstructured":"Khire U.; Liu X. G.; Nagarathnam D.; Wood J.; Wang L.; Liu D.; Zhao J.; Guernon L.; Zhang L.; Quinolone carboxylic acid derivatives for treatment of hyper proliferative conditions 2007","journal-title":"Quinolone carboxylic acid derivatives for treatment of hyper proliferative conditions"},{"key":"ref=104","author":"Dumas J.","year":"2006","unstructured":"Dumas J.; Khire U.; Lasch S.; Nagarathnam D.; Scott W.J.; Methods of treating cancer with quinolone carboxylic acid derivatives 2006","journal-title":"Methods of treating cancer with quinolone carboxylic acid derivatives"},{"key":"ref=105","author":"Yang B.V.","year":"2005","unstructured":"Yang B.V.; Substituted quinoline-2-one derives as antiproliferative agents 2005","journal-title":"Substituted quinoline-2-one derives as antiproliferative agents"},{"key":"ref=106","author":"Kuo S.C.","year":"2005","unstructured":"Kuo S.C.; Huang L. J.; Lai Y. Y.; Chen C.J.; Hsu M.H.; Fang Y. L.; Lee K.H.; Tang C. M.; Substituted 2-Phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents 2005","journal-title":"Substituted 2-Phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents"},{"key":"ref=107","author":"Whitten J.P.","year":"2010","unstructured":"Whitten J.P.; Pierre F.; Regan C.; Schwaebe M.; Nagasawa J.Y.; Chua P.; Quinolone analogs 2010","journal-title":"Quinolone analogs"},{"key":"ref=108","author":"Kuo S.C.","year":"2015","unstructured":"Kuo S.C.; Teng C.M.; Lee K.H.; Huang L.J.; Chou L.C.; Chang C.S.; Sun C.M.; Wu T.S.; Pan S.L.; Way T.D.; Lee J.C.; Chung J.G.; Yang J.S.; Chen C.T.; Huang C.C.; Huang S.M.; Hydrophilic derivatives of 2-selenophene-4-quinolones as anticancer agents 2015","journal-title":"Hydrophilic derivatives of 2-selenophene-4-quinolones as anticancer agents"},{"key":"ref=109","author":"Pommier Y.","year":"2014","unstructured":"Pommier Y.; Marchand C.; Selvam P.; Dexheimer T.; Maddali K.; Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-dnaphosphodiesterase (TDP1). 2014"},{"key":"ref=110","author":"Chu K.S.","year":"2007","unstructured":"Chu K.S.; Che-Ming T.; Kuo-Hsiung L.; Li-Jiau H.; Li-Chen C.; Chih-Shiang C.; Chung-Ming S.; Tian-Shung W.; Shiow-Lin P.; Tzong-Der W.; Jang-Chang L.; Novel hydrophilic derivatives of 2-Aryl-4-quinolones as anticancer agents 2007","journal-title":"Novel hydrophilic derivatives of 2-Aryl-4-quinolones as anticancer agents"},{"key":"ref=111","author":"Nagasawa J.Y.","year":"2014","unstructured":"Nagasawa J.Y.; Pierre F.; Haddach M.; Schwaebe M.; Darjania L.; Whitten J.P.; Quinolone analogs and methods related thereto 2014","journal-title":"Quinolone analogs and methods related thereto"},{"key":"ref=112","author":"Yang B.V.","year":"2004","unstructured":"Yang B.V.; Heterocyclic substituted quinolone-2-one derivatives as anticancer agents 2004","journal-title":"Heterocyclic substituted quinolone-2-one derivatives as anticancer agents"},{"key":"ref=113","author":"Joseph B.","year":"2003","unstructured":"Joseph B.; Darro F.; Guillaumet G.; Kiss R.; Frydman A.; Pharmaceutical compositions comprising 4-quinolones for treating cancers 2003","journal-title":"Pharmaceutical compositions comprising 4-quinolones for treating cancers"},{"key":"ref=114","author":"Lee K.H.","year":"2003","unstructured":"Lee K.H.; Xia Y.; Yang Z.Y.; Kuo S.C.; Fluorinated quinolones as antimitotic and antitumor agents 2003","journal-title":"Fluorinated quinolones as antimitotic and antitumor agents"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/190213","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/190213\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/190213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T14:24:34Z","timestamp":1697552674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/190213\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557521666210112142136","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}